temozolomide has been researched along with Carcinoma, Transitional Cell in 1 studies
Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, M | 1 |
| Wang, Q | 1 |
| Chen, L | 1 |
| Zhao, D | 1 |
| Tang, J | 1 |
| Xu, J | 1 |
| He, Z | 1 |
1 other study available for temozolomide and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
LncRNA UCA1/miR-182-5p/MGMT axis modulates glioma cell sensitivity to temozolomide through MGMT-related DNA damage pathways.
Topics: Animals; Carcinoma, Transitional Cell; Cell Line, Tumor; DNA; DNA Damage; DNA Modification Methylase | 2022 |